Main Article Content


The prevalence of iron deficiency anaemia among women during pregnancy is of concern and a cause of considerable
morbidity and mortality. Anaemia results in an increased number of preterm births, IUGR, PPH, failure of lactation and
increased risk of infections in the postpartum period. Oral iron therapy has less compliance due to inadequate absorption
and side effects and in such conditions parenteral iron therapy like Intravenous sucrose is preferred.
Patients and methods
This study was prospective, comparative and interventional. The total duration of the study was six months. Two groups,
each of 50 antenatal women were given ferrous sulphate and Intravenous sucrose. All antenatal women were reviewed
after four weeks, and they were enquired about compliance, and adverse effects and the haematological investigations
were repeated to know the post-treatment response. Unpaired t test and Chi square tests were used for statistical analysis
and p value <0.01 was taken as highly significant (HS).
Rise of Haemoglobin by 2.5g% was seen in IV sucrose group when compared to rise by 1.3g% in Oral group. Mean rise of
PCV was 2.68± 1.13 with oral iron and mean rise of PCV was5.7± 2.77 with IV iron sucrose, both were HS but Mean rise
in MCV values was not significant. Adverse effects were less in IV sucrose group and hence more compliance.
I.V Iron sucrose was found to be more effective in the treatment of moderate anaemia in antenatal women with less
adverse effects and better tolerance.


Haemoglobin Packed cell volume (PCV) Mean Corpuscular Volume (MCV) Tolerance and Compliance

Article Details

How to Cite
Madhavi Pudutha, Rajasulochana Pisipati, Chandrakala Kambar, & Venkataramana Vund. (2019). Intravenous iron sucrose versus oral ferrous sulphate therapy in moderate anaemia of antenatal women- a comparative study. International Journal of Research in Pharmacology & Pharmacotherapeutics, 8(4), 504-511.


  2. [1]. UNICEF\UNO\WHO GENEVA, 2001. Iron deficiency anaemia, assessment, prevention and control.
  3. [2]. Judith A. Noronha, Aparna Bhaduri, H. Vinod Bhat. Prevalence of anaemia among pregnant women:
  4. community - based study in Udupi district. Health and Population: Perspectives and Issues, 31(1), 31-40.
  5. [3]. Batool A. Haider, Anaemia, prenatal iron use, and risk of adverse effects, Pregnancy outcomes: systematic
  6. review and Meta-analysis BMJ 2013, f3443 DOI: 10.1136/bmj.f3443.
  7. [4]. Ivan EA, Mangaiarkkarasi A. Evaluation of Anaemia in Booked Antenatal Mothers during the Last Trimester.
  8. Journal of Clinical and Diagnostic research. 7(11), 2013, 2487-90.
  9. [5]. Jiji DB, Rajagopal K. A Study to assess the pregnant women the knowledge and risk factors of anaemia among
  10. the pregnant women selected and attending Healthcare facilities in Sebha, Libya. Journal of Science. 4(1),
  11. 2014, 19-22.
  12. [6]. Patra S, Pasrija S, Trivedi SS, Puri M. Maternal and Perinatal outcome in patients with severe anaemia in
  13. pregnancy. International Journal of Gynaecology and obstetrics. 91, 2005, 164-5.
  14. [7]. Kalaivani K. Prevalence and consequences of anaemia in pregnancy. Indian J Med Res. 130(5), 2009, 627-33.
  15. [8]. Theresa OS. Iron status during pregnancy: setting the stage for mother and infant. AmJ.ClinNutr. 81, 2005,
  16. 1218S-22S.
  17. [9]. Scot BS and George MR. Parental iron therapy option. Am J 76, 2004, 74-8.
  18. [10]. Chandler G, Harchowal J, Macdougall IC. Intravenous iron sucrose: establishing a safe dose. Am J Kidn Dis.
  19. 38, 2001, 988-91.
  20. [11]. Dutta DC. Medical illness complicating pregnancy, Textbook of Obstetrics, 6th Edition. [Ed Konar H] The
  21. central Book Agency Pvt Ltd. Culcutta; 2004, 262- 271.
  22. [12]. Bhupesh Dewan, Nisha Philipose, and Aarthi Balasubramanian. Assessment of intravenous Iron Sucrose in the
  23. Management of Anemia in Gynecological and Obstetrical Practice. ObstetGynecol India. 62(3), 2012, 281–
  24. 285.
  25. [13]. Aggarwal RS, Mishra VV, Panchal NA, Patel NH, Deshchougule VV, Jasani AF. Evaluation of iron sucrose
  26. and oral iron in the management of Iron Deficiency Aaemia in pregnancy NJCM. 93, 2012, 415-16.
  27. [14]. Momen AI, Meshariet AK. Intravenous Iron sucrose complex in the treatment of iron deficiency anemia during
  28. pregnancy. Eur J Obstet Gynecol Reprod Biol. 69, 1996, 121-4.
  29. [15]. Bayoumeu F, Subiran-Buisset C, Baka NE, Legagneur H, Monnier- Barbarino P, Laxenaire MC: Iron therapy
  30. in iron deficiency anemia in pregnancy: Intravenous route versus oral route. Am J Obstet Gynecol. 186(3),
  31. 2002, 518-522.